FBRX Earnings

Quarterly EPS
$-4.54
Q3 2024
$-1.17
Q4 2024
$-1.37
Q1 2025
$-0.96
Q2 2025
$-0.99
Q3 2025
$-1.38
Q4 2025
$-1.24
Q1 2026
$-0.97
Q2 2026
Latest RevenueN/A
Latest Net Income-23331000
EPS & Revenue Trend
PeriodEPSRevenueNet IncomeRev YoYEPS YoY
Q2 2026-$0.970-23331000-1.0%
Q1 2026-$1.240-22136000+9.5%
Q4 2025-$1.380-24788000-17.9%
Q3 2025-$0.990-17682000+78.2%
Q2 2025-$0.960-11249000+85.8%
Q1 2025-$1.370-15656000+66.0%
Q4 2024-$1.170-7155000+33.9%
Q3 2024-$4.540-8392000+30.9%
Q2 2024-$6.780-12511000
Q1 2024-$4.030-7420000
Q4 2023-$1.770-5872000
Q3 2023-$6.570-9955000
Forte Biosciences (FBRX) — Earnings